ADENOCARCINOMA OF THE PROSTATE
Clinical trials for ADENOCARCINOMA OF THE PROSTATE explained in plain language.
Never miss a new study
Get alerted when new ADENOCARCINOMA OF THE PROSTATE trials appear
Sign up with your email to follow new studies for ADENOCARCINOMA OF THE PROSTATE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New radiation combo aims to safely treat prostate cancer
Disease control OngoingThis early-phase study tests the safety of combining two types of radiation therapy for men with intermediate-risk prostate cancer. Participants receive a short internal radiation treatment followed by three weeks of highly targeted external radiation. The goal is to see if this …
Matched conditions: ADENOCARCINOMA OF THE PROSTATE
Phase: PHASE1 • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University • Aim: Disease control
Last updated May 17, 2026 06:52 UTC
-
New proton beam method targets hidden prostate tumors to prevent return
Disease control OngoingThis study tests whether a higher dose of proton radiation, precisely aimed at tumors seen on MRI, can better control high-risk prostate cancer. About 100 participants will receive radiation over 8-9 weeks, plus hormone therapy for 18 months. The main goal is to see if this appro…
Matched conditions: ADENOCARCINOMA OF THE PROSTATE
Phase: PHASE2 • Sponsor: University of Florida • Aim: Disease control
Last updated May 17, 2026 06:49 UTC
-
Promising combo tackles tough prostate cancer
Disease control OngoingThis study tests a three-part treatment for men with intermediate or high-risk prostate cancer: a drug called enzalutamide, radiation therapy, and hormone therapy. The goal is to see how safe the combination is and how well it controls the cancer. About 25 men will take part, and…
Matched conditions: ADENOCARCINOMA OF THE PROSTATE
Phase: PHASE1 • Sponsor: Thomas Jefferson University • Aim: Disease control
Last updated May 15, 2026 11:55 UTC
-
High-Dose radiation zaps prostate tumors with less harm to healthy tissue
Disease control OngoingThis study tests a special type of radiation called stereotactic body radiotherapy (SBRT) for men with high-risk prostate cancer that has not spread. SBRT delivers a very focused, high dose of radiation directly to the tumor, aiming to kill cancer cells while sparing normal tissu…
Matched conditions: ADENOCARCINOMA OF THE PROSTATE
Phase: NA • Sponsor: Jonsson Comprehensive Cancer Center • Aim: Disease control
Last updated May 14, 2026 12:01 UTC
-
Smarter hormone therapy aims to control advanced prostate cancer with fewer side effects
Disease control OngoingThis study tests a new way of giving hormone therapy for stage IV prostate cancer that has not yet stopped responding to hormones. Instead of continuous treatment, the therapy is given in cycles based on PSA levels. The goal is to keep the cancer under control while reducing side…
Matched conditions: ADENOCARCINOMA OF THE PROSTATE
Phase: EARLY_PHASE1 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Disease control
Last updated May 13, 2026 16:03 UTC